Scientists still aren’t sure what causes Parkinson’s disease, a debilitating, progressive neurological disorder. They do know it develops when nerve cells that produce a chemical called dopamine become damaged and die.
At the DaSilva Institute, we use a remarkable intravenous therapy called IV glutathione to help slow the process of nerve-cell degeneration.
Levels of glutathione, a naturally occurring brain-protecting antioxidant, are significantly decreased in Parkinson’s patients, with the deficiency occurring in the portion of the brain where dopamine-generating neurons are concentrated.
For many Parkinson’s sufferers, glutathione replenishment has proven to be an effective therapy for halting or even potentially reversing disability. In patients who respond to this therapy, the effects can be almost immediate and dramatic. Within an hour of treatment, patients often experience reduced rigidity, fewer tremors, and improved walking ability.
{What about Alzheimer’s??}